MedPath

Study of noscapine in Buerger's disease

Phase 2
Conditions
Buerger's disease.
Thromboangiitis obliterans [Buerger's disease]
I73.1
Registration Number
IRCT20180103038199N5
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
15
Inclusion Criteria

less than 50 years old
history of cigarette consumption
Upper limb involvement or migratory thrombophlebitis
Infra-popliteal vascular involvement

Exclusion Criteria

No burning pain and paresthesia at the time of referral
Symptoms of allergies and drug allergies
More than 2-fold increase in upper limit of liver enzymes
More than 2-fold increase in upper limit of renal function parameters
Lack of consent for continued intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of pain using Visual Analogue Scale (VAS) scoring method. Timepoint: every week. Method of measurement: questionnaire of Visual Analogue Scale of pain.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath